Advanced pancreatic cancer. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy8

Cell Line, Tumor Pancreas Tumor Cells, Cultured Pancreatic Ducts Pancreatic Stellate Cells Neoplastic Stem Cells Pancreatic Juice Breast

Organisms4

Mice, Nude Mice, SCID Mice, Inbred BALB C Adenoviridae

Diseases46

Pancreatic Neoplasms Adenocarcinoma Carcinoma, Pancreatic Ductal Disease Progression Neoplasm Metastasis Cachexia Carcinoma Neoplasm Invasiveness Neutropenia Thrombocytopenia Prostatic Neoplasms Ovarian Neoplasms Lung Neoplasms Breast Neoplasms Pain Pancreatitis Colonic Neoplasms Stomach Neoplasms Neoplasms Genetic Predisposition to Disease Pancreatitis, Chronic Cell Transformation, Neoplastic Neovascularization, Pathologic Uterine Cervical Neoplasms Colorectal Neoplasms Liver Neoplasms Carcinoma, Non-Small-Cell Lung Carcinoma, Squamous Cell Neoplasm Recurrence, Local Precancerous Conditions Urinary Bladder Neoplasms Disease Models, Animal Gastrointestinal Neoplasms Rectal Neoplasms Carcinoma in Situ Endometrial Neoplasms Esophageal Neoplasms Peritoneal Neoplasms Neoplastic Syndromes, Hereditary Adenocarcinoma, Mucinous Pancreatic Diseases Neoplasms, Experimental Head and Neck Neoplasms Skin Neoplasms Mouth Neoplasms Neoplasms, Hormone-Dependent

Chemicals and Drugs64

Deoxycytidine CA-19-9 Antigen Antimetabolites, Antineoplastic Fluorouracil Oxonic Acid Antineoplastic Agents Quinazolines Organoplatinum Compounds Tegafur Radiation-Sensitizing Agents Tumor Markers, Biological Cisplatin Leucovorin Camptothecin Drug Combinations Antibodies, Monoclonal, Humanized Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Placebos Antibodies, Monoclonal Paclitaxel Neoplasm Proteins RNA, Messenger RNA, Small Interfering Cancer Vaccines DNA, Neoplasm Antigens, Neoplasm Smad4 Protein Tumor Suppressor Protein p53 MicroRNAs Antigens, Tumor-Associated, Carbohydrate Receptor, erbB-2 Mucin-4 Proto-Oncogene Proteins Antineoplastic Agents, Phytogenic Receptors, Estrogen RNA, Neoplasm ras Proteins Anticarcinogenic Agents Carcinoembryonic Antigen Mucin-1 Tumor Suppressor Proteins Proto-Oncogene Proteins c-akt Prostate-Specific Antigen DNA-Binding Proteins BRCA2 Protein Vascular Endothelial Growth Factor A Transcription Factors Tamoxifen Cadherins Nuclear Proteins GPI-Linked Proteins Receptors, Progesterone NF-kappa B Protein-Serine-Threonine Kinases Carcinogens Curcumin Antineoplastic Agents, Hormonal Enzyme Inhibitors Proto-Oncogene Proteins p21(ras)Proto-Oncogene Proteins c-bcl-2 Cyclooxygenase 2 Cell Cycle Proteins Taxoids

Analytical, Diagnostic and Therapeutic Techniques and Equipment85

Antineoplastic Combined Chemotherapy Protocols Treatment Outcome Palliative Care Combined Modality Therapy Survival Analysis Heavy Ion Radiotherapy Disease-Free Survival Survival Rate Pancreatectomy Drug Administration Schedule Chemoradiotherapy Infusions, Intravenous Pancreaticoduodenectomy Jejunostomy Prognosis Chemoradiotherapy, Adjuvant Neoplasm Staging Maximum Tolerated Dose Kaplan-Meier Estimate Neoadjuvant Therapy Chemotherapy, Adjuvant Clinical Trials, Phase III as Topic Radiotherapy, Conformal Early Detection of Cancer Radiotherapy, Adjuvant Radiation Dosage Retrospective Studies Clinical Trials as Topic Randomized Controlled Trials as Topic Xenograft Model Antitumor Assays Radiotherapy Dosage Prospective Studies Follow-Up Studies Placebos Feasibility Studies Tomography, X-Ray Computed Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Administration, Oral Pilot Projects Blotting, Western Transplantation, Heterologous Risk Factors Tumor Burden Immunohistochemistry Gene Expression Profiling Double-Blind Method Risk Odds Ratio Risk Assessment Registries Oligonucleotide Array Sequence Analysis Drug Screening Assays, Antitumor Sensitivity and Specificity Transfection Gene Knockdown Techniques Molecular Targeted Therapy Multivariate Analysis Tissue Array Analysis Polymerase Chain Reaction Endosonography SEER Program Incidence Immunoenzyme Techniques Disease Models, Animal Questionnaires Flow Cytometry Genetic Therapy Predictive Value of Tests Reproducibility of Results Case-Control Studies Cohort Studies Confidence Intervals Logistic Models Models, Biological Drug Delivery Systems DNA Mutational Analysis Radiotherapy Real-Time Polymerase Chain Reaction Neoplasm Grading Mammography Tumor Stem Cell Assay Inhibitory Concentration 50 Neoplasms, Experimental Immunotherapy

Psychiatry and Psychology2

Phenomena and Processes45

Maximum Tolerated Dose Dose-Response Relationship, Drug Radiation Dosage Gene Expression Regulation, Neoplastic Time Factors Cell Proliferation Apoptosis Drug Resistance, Neoplasm Pain Genetic Predisposition to Disease Cell Growth Processes Cell Survival Cell Movement Signal Transduction Mutation Risk RNA Interference Down-Regulation Genes, ras Odds Ratio Cell Division Up-Regulation Cell Cycle Sensitivity and Specificity Drug Synergism Gene Silencing Epithelial-Mesenchymal Transition DNA Methylation Transfection Genotype Genes, Neoplasm Germ-Line Mutation Phosphorylation Promoter Regions, Genetic Genes, Tumor Suppressor Genes, BRCA1 Gene Expression Diet Genes, BRCA2 Polymorphism, Genetic Genes, p53 Base Sequence Tumor Microenvironment Phenotype Inhibitory Concentration 50

Disciplines and Occupations2

Medical Oncology Immunohistochemistry

Anthropology, Education, Sociology and Social Phenomena2

Quality of Life National Cancer Institute (U.S.)

Humanities1

Quality of Life

Information Science8

Survival Rate Radiotherapy, Conformal Registries SEER Program Incidence Questionnaires Base Sequence Molecular Sequence Data

Named Groups1

Health Care35

Treatment Outcome Palliative Care Survival Analysis Disease-Free Survival Survival Rate Congresses as Topic Kaplan-Meier Estimate Clinical Trials, Phase III as Topic Radiation Dosage Retrospective Studies Clinical Trials as Topic Randomized Controlled Trials as Topic Prospective Studies Follow-Up Studies Feasibility Studies Pilot Projects Risk Factors Double-Blind Method Risk Odds Ratio Risk Assessment Registries Sensitivity and Specificity Multivariate Analysis National Cancer Institute (U.S.)Age Factors SEER Program Incidence Questionnaires Predictive Value of Tests Reproducibility of Results Case-Control Studies Cohort Studies Confidence Intervals Logistic Models

Geographicals3

United States Japan China

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Humanities Information Science Named Groups Health Care Geographicals

Pancreatic Neoplasms Deoxycytidine CA-19-9 Antigen Antimetabolites, Antineoplastic Adenocarcinoma Fluorouracil Antineoplastic Combined Chemotherapy Protocols Carcinoma, Pancreatic Ductal Treatment Outcome Palliative Care Combined Modality Therapy Survival Analysis Heavy Ion Radiotherapy Oxonic Acid Disease-Free Survival Disease Progression Survival Rate Pancreatectomy Drug Administration Schedule Antineoplastic Agents Congresses as Topic Quinazolines Chemoradiotherapy Organoplatinum Compounds Infusions, Intravenous Tegafur Pancreaticoduodenectomy Cell Line, Tumor Jejunostomy Prognosis Neoplasm Metastasis Radiation-Sensitizing Agents Chemoradiotherapy, Adjuvant Neoplasm Staging Tumor Markers, Biological Cisplatin Maximum Tolerated Dose Kaplan-Meier Estimate Neoadjuvant Therapy Cachexia Leucovorin Chemotherapy, Adjuvant Carcinoma Clinical Trials, Phase III as Topic Dose-Response Relationship, Drug Radiotherapy, Conformal Mice, Nude Medical Oncology Camptothecin Drug Combinations Early Detection of Cancer Radiotherapy, Adjuvant Radiation Dosage Retrospective Studies Clinical Trials as Topic Gene Expression Regulation, Neoplastic Antibodies, Monoclonal, Humanized Neoplasm Invasiveness Randomized Controlled Trials as Topic Xenograft Model Antitumor Assays Radiotherapy Dosage Prospective Studies Follow-Up Studies Protein Kinase Inhibitors Receptor, Epidermal Growth Factor Quality of Life Time Factors Placebos Antibodies, Monoclonal Paclitaxel Cell Proliferation Neutropenia Thrombocytopenia Pancreas Feasibility Studies Tomography, X-Ray Computed Reverse Transcriptase Polymerase Chain Reaction Neoplasm Transplantation Apoptosis Prostatic Neoplasms Neoplasm Proteins Ovarian Neoplasms Drug Resistance, Neoplasm Lung Neoplasms Breast Neoplasms Pain Pancreatitis Colonic Neoplasms Stomach Neoplasms Administration, Oral Neoplasms RNA, Messenger Pilot Projects RNA, Small Interfering Tumor Cells, Cultured Blotting, Western Genetic Predisposition to Disease Pancreatitis, Chronic Transplantation, Heterologous Cell Growth Processes

No FAQ available that match "advanced pancreatic cancer"